Pfizer stock has delivered its long-term shareholders a dividend that has grown for 16 consecutive years. The pace of those ...

Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...

At recent prices, the stock offers a huge 6.6% dividend yield. In 2024, sales of a next-generation blood thinner called Eliquis grew 9% to $7.4 billion for Pfizer. That works out to 11.6% of total ...

Nearly 300 employees in Lawrenceville will lose their jobs as part of a pharmaceutical company's major cost-cutting measures, officials said.Bristol Myers Squibb will lay off at least 290 employees in ...

Abecma made $406 million in 2024, of which BMS paid $43 million to 2seventy bio as part of their profit-sharing agreement.

Treatment for DVT often involves blood thinners and in some cases ... medication (think drugs such as Coumadin, Pradaxa and Eliquis) for six months and then be re-evaluated.

Pfizer's attractive dividend yield and low P/E ratio make it appealing. Learn why PFE stock's valuation risks may be higher ...

Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s ...

Eliquis is taken to treat or prevent blood clots (such as ... Xarelto is a factor Xa inhibitor and works by preventing the coagulation cascade. Unlike the other blood thinners discussed, Xarelto has ...

The blood thinner Eliquis—developed and commercialized through the powerhouse partnership between Bristol Myers Squibb and Pfizer—made $13.3 billion in 2024, representing a 9% year-on-year increase in ...